These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3602915)

  • 1. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension.
    Os I; Kjeldsen SE; Westheim A; Lande K; Norman N; Hjermann I; Eide I
    Scand J Clin Lab Invest; 1987 Jun; 47(4):371-7. PubMed ID: 3602915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects.
    Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB
    J Hum Hypertens; 1988 Oct; 2(3):199-202. PubMed ID: 3236324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased central dopaminergic activity in essential hypertension.
    Os I; Kjeldsen SE; Westheim A; Aakesson I; Norman N; Enger E; Hjermann I; Eide I
    J Hypertens; 1987 Apr; 5(2):191-7. PubMed ID: 3611768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine administration on cecal mechanical activity and cecal blood flow in conscious healthy horses.
    Clark ES; Moore JN
    Am J Vet Res; 1989 Jul; 50(7):1084-8. PubMed ID: 2774332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB; Pedersen EB
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
    Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
    Scand J Clin Lab Invest; 1989 Jun; 49(4):307-15. PubMed ID: 2525805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.
    Gudbjörnsdottir S; Elam M; Sellgren J; Anderson EA
    J Hypertens; 1996 Jan; 14(1):91-7. PubMed ID: 12013500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine infusion in patients with hepatic encephalopathy: plasma levels and haemodynamic changes.
    Lenz K; Hörtnagl H; Unger H; Druml W; Laggner A; Grimm G; Schneeweisz B
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():85-9. PubMed ID: 2083941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
    Pagniez F; Valentin JP; Vieu S; Colpaert FC; John GW
    Br J Pharmacol; 1998 Jan; 123(2):205-14. PubMed ID: 9489607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
    Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-induced changes in renal blood flow in normals and in patients with renal dysfunction.
    Drieghe B; Manoharan G; Heyndrickx GR; Madaric J; Bartunek J; Sarno G; Vanderheyden M; De Bruyne B
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):725-30. PubMed ID: 18949800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine infusion on forearm blood flow in critical patients.
    Piazza O; Zito G; Valente A; Tufano R
    Med Sci Monit; 2006 Feb; 12(2):CR90-3. PubMed ID: 16449954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
    Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
    Carey RM; Stote RM; Dubb JW; Townsend LH; Rose CE; Kaiser DL
    J Clin Invest; 1984 Dec; 74(6):2198-207. PubMed ID: 6150942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.